Literature DB >> 10772606

Treatment resistant smokers: a pilot study of nicotine nasal spray and inhaler.

J R Hughes1, J A Grass, J L Pillitteri.   

Abstract

A growing proportion of smokers are those who have failed prior treatments for cessation. We tested the efficacy of nicotine nasal spray and nicotine inhaler in two uncontrolled, open-label studies of 19 and 20 smokers who had previously failed nicotine patch therapy. As in the three prior studies of treatment failures, 6 month abstinence rates were extremely low both with the nasal spray (0%) and the inhaler (5%). We discuss possible treatments for and methodological issues in researching treatment-resistant smokers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10772606     DOI: 10.1300/J069v19n01_08

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  5 in total

Review 1.  Interventions to address chronic disease and HIV: strategies to promote smoking cessation among HIV-infected individuals.

Authors:  Raymond Niaura; Geetanjali Chander; Heidi Hutton; Cassandra Stanton
Journal:  Curr HIV/AIDS Rep       Date:  2012-12       Impact factor: 5.071

2.  Treatment non-response: Associations with smoking expectancies among treatment-seeking smokers.

Authors:  Lorra Garey; Samar A Taha; Brooke Y Kauffman; Kara F Manning; Clayton Neighbors; Norman B Schmidt; Michael J Zvolensky
Journal:  Addict Behav       Date:  2017-05-09       Impact factor: 3.913

Review 3.  Smoking cessation: significance and implications for children.

Authors:  Andrea T Borchers; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 4.  Clinical efficacy of bupropion in the management of smoking cessation.

Authors:  Douglas Jorenby
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Retreatment with varenicline for smoking cessation in smokers who have previously taken varenicline: a randomized, placebo-controlled trial.

Authors:  D Gonzales; P Hajek; L Pliamm; K Nackaerts; L-J Tseng; T D McRae; J Treadow
Journal:  Clin Pharmacol Ther       Date:  2014-06-09       Impact factor: 6.875

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.